|
|||||
|
|
| Latest Insider Trading | Top Insider Trading Recent Week | Top 10% Owner Trading Recent Week | Filter
|
| Ticker | Owner | Relationship | Date | Transaction | Cost |
#Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| BEAM | Simon Amy | Chief Medical Officer | Jul 01 '25 | Sale | 16.94 | 374 | 6,336 | 65,740 | Jul 03 05:30 PM |
| BEAM | Simon Amy | Chief Medical Officer | Jul 03 '25 | Sale | 20.12 | 876 | 17,625 | 64,864 | Jul 03 05:30 PM |
| BEAM | Simon Amy | Chief Medical Officer | Apr 01 '25 | Sale | 18.35 | 9,566 | 175,542 | 86,739 | Apr 03 09:50 PM |
| BEAM | Simon Amy | Chief Medical Officer | Apr 02 '25 | Sale | 17.73 | 20,997 | 372,294 | 65,742 | Apr 03 09:50 PM |
| BEAM | AMY SIMON | Officer | Apr 02 '25 | Proposed Sale | 17.73 | 20,997 | 372,294 | Apr 02 04:08 PM | |
| BEAM | AMY SIMON | Officer | Apr 01 '25 | Proposed Sale | 22.21 | 30,562 | 678,782 | Mar 31 06:44 PM | |
| BEAM | Simon Amy | Chief Medical Officer | Jul 01 '24 | Sale | 23.76 | 502 | 11,928 | 69,553 | Jul 03 04:05 PM |
| BEAM | Simon Amy | Chief Medical Officer | Jul 02 '24 | Sale | 22.95 | 748 | 17,167 | 68,805 | Jul 03 04:05 PM |
| BEAM | Simon Amy | Chief Medical Officer | Apr 01 '24 | Sale | 32.13 | 7,157 | 229,954 | 86,590 | Apr 03 07:43 PM |
| BEAM | Simon Amy | Chief Medical Officer | Apr 02 '24 | Sale | 30.54 | 16,530 | 504,851 | 70,060 | Apr 03 07:43 PM |
| BEAM | Simon Amy | Chief Medical Officer | Oct 30 '23 | Sale | 18.70 | 3,448 | 64,478 | 65,469 | Nov 01 04:30 PM |
| BEAM | Simon Amy | Chief Medical Officer | Jul 10 '23 | Sale | 30.48 | 391 | 11,918 | 68,917 | Aug 09 04:08 PM |
| BEAM | Simon Amy | Chief Medical Officer | Apr 03 '23 | Sale | 30.31 | 4,445 | 134,728 | 80,962 | Apr 05 08:30 PM |
| BEAM | Simon Amy | Chief Medical Officer | Apr 04 '23 | Sale | 29.70 | 11,654 | 346,115 | 69,308 | Apr 05 08:30 PM |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite